Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The augmin complex, also known as the HAUS complex, is an evolutionarily conserved hetero-octameric protein assembly (comprising subunits HAUS1 through HAUS8) that is essential for the organization of the mitotic spindle. Its primary biological role is to facilitate branching microtubule nucleation by recruiting the γ-tubulin ring complex (γ-TuRC) to the lateral surfaces of pre-existing microtubules, thereby amplifying the spindle microtubule density required for accurate chromosome segregation and cytokinesis. Beyond mitosis, the complex is also vital for non-centrosomal microtubule organization in neurons, supporting axonal growth and dendritic development. In clinical contexts, the augmin complex is increasingly recognized as a potential therapeutic target in oncology; elevated expression of its subunits, such as HAUS1 and HAUS3, is strongly associated with poor prognosis and tumor progression in cancers like hepatocellular carcinoma and glioma. While no specific clinical drugs are currently approved, experimental disruption of the complex leads to mitotic delay, multipolar spindle formation, and p53-dependent apoptosis, suggesting that small-molecule inhibitors of its assembly or its interaction with γ-TuRC could serve as effective anti-mitotic chemotherapeutic agents. However, therapeutic challenges include managing potential toxicity related to its role in healthy dividing cells and its critical functions in neurodevelopment.
Potential therapeutic strategies involve the disruption of branching microtubule nucleation by inhibiting the interaction between the augmin complex and the γ-tubulin ring complex (γ-TuRC) or its recruitment factor NEDD1, leading to mitotic arrest and apoptosis in cancer cells.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Augmin complex (HAUS) (HAUS).